Cross Country Healthcare reports Q4 2024 revenue down 25% YoY, net loss of $3.8M

CROSS COUNTRY HEALTHCARE INC

Q4 2024 revenue $309.9M, down 25% YoY and 2% sequentially.
Q4 net loss $3.8M ($0.12 diluted EPS); full year net loss $14.6M.
Adjusted EBITDA $9.3M (-55% YoY); adjusted EPS $0.04.
Full year 2024 revenue $1.34B, down 33% from 2023.
Operating cash flow Q4 $24.2M, up 101% YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.